Key Highlights

  • Mirion Technologies (NYSE:MIR) reports third-quarter results after the close on Tuesday, October 27, 2026, with consensus adjusted earnings of USD 0.12 per share, equal to the second-quarter result.
  • Second-quarter revenue rose 19.7% to USD 266.8 million, adjusted EBITDA was USD 65.3 million, a margin of 24.5%, and orders excluding acquisitions rose 10% to USD 229 million.
  • Full-year guidance reaffirmed in July calls for revenue growth of 22.0% to 24.0%, organic growth of 5.0% to 7.0% and adjusted earnings of USD 0.48 to USD 0.55 per share.
  • The shares fell about 9.4% after the July report, so organic growth is the main test, and the Federal Reserve decides on Wednesday, October 28, 2026.

The Setup and Reaffirmed Guidance

Mirion Technologies (NYSE:MIR) makes radiation detection, measurement and monitoring equipment for nuclear power, defence, medical and laboratory customers, and it reports third-quarter results after the close on Tuesday, October 27, 2026. Consensus adjusted earnings are USD 0.12 per share. In the release of Tuesday, July 28, 2026, second-quarter revenue rose 19.7% to USD 266.8 million, and adjusted earnings were USD 0.12 per share compared with USD 0.11 a year earlier. Adjusted EBITDA, which is earnings before interest, tax, depreciation and amortisation, was USD 65.3 million. Management reaffirmed full-year revenue growth of 22.0% to 24.0%, adjusted EBITDA of USD 285 million to USD 300 million and adjusted free cash flow of USD 155 million to USD 175 million. Results cannot be known in advance.

Why Organic Growth and Orders Matter

Mirion Technologies (NYSE:MIR) has grown quickly through acquisitions, including Paragon and Certrec, so reported growth of 19.7% overstates the underlying pace. Full-year organic growth is guided to 5.0% to 7.0%, and one analysis of the second quarter noted that margins expanded while organic growth lagged. Orders give a forward view: they reached USD 291 million including the acquisitions, up 40%, and USD 229 million without them, up 10%. Demand from nuclear power operators, supported by new reactor programmes and life extensions of existing plants, underpins the backlog, which the company said was growing. The shares fell about 9.4% after the July report despite the reaffirmed outlook, which shows how closely investors watch organic growth.

Risks and What to Watch

The bull case for Mirion Technologies (NYSE:MIR) is organic growth of 7% or more, orders that confirm the 10% underlying increase and a guidance raise, which would answer the concern that caused the July decline and could drive a strong rebound. The bear case is organic growth below the 5.0% to 7.0% range, softer orders or a trimmed earnings range, which would reinforce the view that acquisitions flatter the growth rate and could extend the fall. Integration of Paragon and Certrec, project timing at utilities and defence budgets are the underlying risks. Investors should watch organic growth, orders, backlog, margin and cash flow, together with the Federal Reserve decision on Wednesday, October 28, 2026.

Where Things Stand

The answer is that Mirion Technologies (NYSE:MIR) can hold its USD 0.48 to USD 0.55 earnings range if the third quarter meets the USD 0.12 consensus, but organic growth and orders are likely to set the share reaction. Acquisitions make reported growth look strong, so the underlying figures carry the debate. The next catalysts are the release on Tuesday, October 27, 2026 and the Federal Reserve decision on Wednesday, October 28, 2026. Consensus figures and guidance are estimates, not guarantees, and this is not investment advice.